focus trial semaglutide Ozempic maker Novo Nordisk says it will study drug's effects on alcohol consumption but isn't focused on addiction Semaglutide Inducing Resolution of Proliferative

Tapering the drug dosage allows the pituitary gland to recover.

Current GLP-1 treatments for obesity consist of daily or weekly injectable medications that come with drawbacks, including the need for cold chain distribution and storage, risk of injection site reactions, and needle-related discomfort

(Source 2) "Think about it this way: being awake causes oxidative stress, and sleep is an antioxidant." Sleep is critical for health, playing a significant role in all body systems including immunity, hormonal health, and the nervous system

Without adequate protein and resistance training, 25 to 40 percent of total weight lost with GLP-1 therapy can come from muscle and other lean mass, including bone

I havent reached my target weight (close to it though), but the sickness was getting too much

PMID: 35677226